NYSE · CBT
Cabot Corp.
Basic Materials · Chemicals - Specialty
$74.43▲ 0.79% ($0.58)at close
As of 4:00 PM ET
Valuation
Revenue & margin DCF
Verdict: fairly priced. Price above Base.
The price needs 12.8% revenue growth a year for 10 years. Our scenarios assume 0.7–4.4%.
That's 5.9× its past 4-year pace.
Value per share
Base case
$27.72
Price used $74.43 is 2.7× this
USD · TTM ending Jun 30, 2026 · Price Oct 30, 8:00 PM UTC
Revenue each value needs
Revenue today $3.6B. The price needs $12.1B by 2036. Base case: $4B. At its recent pace: $4.5B. Bear to Bull: $3.9B to $5.6B.
Revenue today $3.6B. The price needs $12.1B by 2036. Base case: $4B. At its recent pace: $4.5B. Bear to Bull: $3.9B to $5.6B.
Revenue in 2036
today $3.6B
+$8.1Bmore than the Base case · 3.0×
Value per share · Base case
$27.72
Price $74.43
2.7× this
- 10-yr revenue CAGR
- 0.9%
- Ending operating margin
- 7.9%
- Discount rate
- 7.4%
USD · TTM ending Jun 30, 2026 · Price Oct 30, 8:00 PM UTC
What each scenario assumes. Click a column to start from it.
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock rose 10.17% over the last year. Revenue declined 4.74% over the trailing twelve months. Operating margin moved from 16.62% to 13.79%. Free cash flow declined 19.25% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher against modestly weakening underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 13.79%. A decisive move in revenue — currently down 4.74% — would be the clearest signal to resolve the ambiguity.
Return analysis
Company profile
Cabot Corporation operates as a specialty chemicals and performance materials company.
Market multiples
Stock splits
Every 1 shares became 2
Every 1 shares became 2
Every 1 shares became 3
Every 1 shares became 2
Profitability & growth
Analyst consensus
7
Buy
7
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Actuals vs estimates by quarter, or any quarter against the same one a year earlier.
Next report
Nov 2, 2026
Q4 FY26 · EPS est $1.55 · Revenue est $927.3M
Same quarter, year over year
FY26 YTD -13.5%Each cell vs the same quarter a year earlier (the cell below) · Q1–Q3 combined $4.81 vs $5.56 · 0 of 3 quarters up
Q1
Q2
Q3
Q4
FY total
FY26
—
FY25
FY24
FY23
—
—
—
—
Fiscal year totals
- FY25
- $7.26
- +2.8%
- FY24
- $7.06
- —
Q3 FY26
Reported Aug 3, 2026 · Latest
HoverTap a cell to inspect
Actual
$1.67
Estimate
$1.65
Year over year
-12.1%
Vs prior quarter
+3.7%
Institutional Sentiment
Cabot Corp. · CBT
From Form 13F filings (managers with $100M+). Filings land up to 45 days after quarter end — read this as positioning context, not live fund flow.